MedPath

Evaluation of the effect of pretransplant, high-dose intravenous vitamin C in prevention of delayed graft function after deceased kidney transplantatio

Phase 3
Recruiting
Conditions
Complications of kidney transplant.
Complications of kidney transplant
T86.1
Registration Number
IRCT20100111003043N13
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

First kidney transplantation
Brain death donor
Transplant recipient age 14 or more
Patient informed consent to enter the study

Exclusion Criteria

Hemochromatosis
ESRD due to hyperoxaluria
Multi-organ transplantation
Favism history
Preemptive kidney transplantation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dialysis in the first week after the kidney transplant. Timepoint: Daily in the first week after the kidney transplant. Method of measurement: Medical records review.;Serum creatinine. Timepoint: Daily in the first week after kidney transplant then monthly until three months. Method of measurement: Jaffe's reaction.;Urine volume in the first six hours after transplantation. Timepoint: The first six hours after transplantation. Method of measurement: Urine volume.
Secondary Outcome Measures
NameTimeMethod
Acute rejection episode in the first three months after transplantation. Timepoint: the first three months after transplantation. Method of measurement: Medical records review.
© Copyright 2025. All Rights Reserved by MedPath